Evidence map›Paper›PMID 26787722›Full record

ArticleInfection and immunity2016

Roles of Toll-Like Receptor 2 (TLR2), TLR4, and MyD88 during Pulmonary Coxiella burnetii Infection.

Andrew G Ramstead, Amanda Robison, Anne Blackwell, Maria Jerome, Brett Freedman, Kirk J Lubick, Jodi F Hedges, Mark A Jutila

Abstract read
In one paragraph

Article in Infection and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. A Review on the Immunological Response againstPathogens (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Article
  11. Improving CAR T-Cell Persistence.International journal of molecular sciences · 2021
    Review
  12. Recent Advances on the Innate Immune Response toFrontiers in cellular and infection microbiology · 2021
    Review
  13. Article
  14. Article
  15. MyD88 Is Required for Efficient Control ofFrontiers in immunology · 2019
    Article
  16. Pathogenesis of Important Virulence Factors ofFrontiers in cellular and infection microbiology · 2019
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrew G RamsteadDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Amanda RobisonDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Anne BlackwellDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Maria JeromeDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Brett FreedmanDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Kirk J LubickDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Jodi F HedgesDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Mark A JutilaDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA uvsmj@montana.edu.

Funding

Pilot Grants ProgramP30GM110732 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2014 to 2018
$5.4M
Role of Toll-like receptors in Coxiella burnetii infectionR21AI094261 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI JUTILA, MARK A · 2012 to 2013
$385k
NIAID NIH HHS 1 R21 AI094261NIAID NIH HHS R21 AI094261NIGMS NIH HHS GM110732NIGMS NIH HHS P30 GM110732
6 · The paper itself

Abstract

Coxiella burnetii, the causative agent of Q fever, is an obligate intracellular, primarily pulmonary, bacterial pathogen. Although much is known about adaptive immune responses against this bacterium, our understanding of innate immune responses against C. burnetii is not well defined, particularly within the target tissue for infection, the lung. Previous studies examined the roles of the innate immune system receptors Toll-like receptor 2 (TLR2) and TLR4 in peripheral infection models and described minimal phenotypes in specific gene deletion animals compared to those of their wild-type controls (S. Meghari et al., Ann N Y Acad Sci 1063:161-166, 2005,http://dx.doi.org/10.1196/annals.1355.025; A. Honstettre et al., J Immunol 172:3695-3703, 2004,http://dx.doi.org/10.4049/jimmunol.172.6.3695) . Here, we assessed the roles for TLR2, TLR4, and MyD88 in pulmonary C. burnetii infection and compared responses to those that occurred in TLR2- and TLR4-deficient animals following peripheral infection. As observed previously, neither TLR2 nor TLR4 was needed for limiting bacterial growth after peripheral infection. In contrast, TLR2 and, to a lesser extent, TLR4 limited growth (or dissemination) of the bacterium in the lung and spleen after pulmonary infection. TLR2, TLR4, and MyD88 were not required for the general inflammatory response in the lungs after pulmonary infection. However, MyD88 signaling was important for infection-induced morbidity. Finally, TLR2 expression on hematopoietic cells was most important for limiting bacterial growth in the lung. These results expand on our knowledge of the roles for TLR2 and TLR4 in C. burnetii infection and suggest various roles for these receptors that are dictated by the site of infection.

Indexed as

AnimalsChimeraCoxiella burnetiiGene Expression RegulationLung DiseasesMiceMice, KnockoutMyeloid Differentiation Factor 88PeritonitisQ FeverToll-Like Receptor 2Toll-Like Receptor 4Myd88 protein, mouseMyeloid Differentiation Factor 88Tlr2 protein, mouseTlr4 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID26787722
PMCPMC4807485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.